文献速递淋巴瘤白血病

NG2抗原参与MLL重排婴儿B-ALL的白血病侵袭性和中枢神经系统浸润

NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.
PubMed 文献 · Leukemia · 2017-09-25

本研究探讨NG2在MLL重排婴儿B细胞急性淋巴细胞白血病(iMLLr-B-ALL)中是否区分白血病起始/传播细胞和中枢神经系统浸润细胞。Interfant队列临床数据显示高NG2表达与较低无事件生存、较高循环原始细胞数及更频繁中枢神经系统疾病/复发相关。系列异种移植表明NG2是可塑标志,不富集白血病起始细胞或中枢神经系统浸润细胞,但NG2在髓外造血部位和中枢神经系统浸润的原始细胞中高度上调,特异性阻断NG2导致几乎完全丧失植入。

要点

  • 高NG2表达与iMLLr-B-ALL较低无事件生存、较高循环原始细胞数及更频繁中枢神经系统疾病/复发相关。
  • 系列异种移植显示NG2是可塑标志,不富集白血病起始/传播细胞或中枢神经系统浸润细胞。
  • NG2在髓外造血部位和中枢神经系统浸润的原始细胞中高度上调,特异性阻断NG2导致几乎完全丧失植入。

核心结论

  • 本研究为NG2在iMLLr-B-ALL中的生物学提供了新见解,并提示NG2作为潜在治疗靶点以降低中枢神经系统疾病/复发风险并提供更安全的中枢神经系统导向治疗。

研究设计与样本

  • 研究评估NG2是否区分iMLLr-B-ALL中的白血病起始/传播细胞和/或中枢神经系统浸润细胞,包括Interfant队列临床数据分析、原代MLL-AF4+白血病的系列异种移植及原代原始细胞和原代移植物的基因表达谱分析。

主要发现

  • Interfant队列iMLLr-B-ALL临床数据显示高NG2表达与较低无事件生存、较高循环原始细胞数及更频繁中枢神经系统疾病/复发相关。
  • 系列异种移植表明NG2是可塑标志,不富集iMLLr-B-ALL中的白血病起始/传播细胞或中枢神经系统浸润细胞。
  • NG2表达在浸润髓外造血部位和中枢神经系统的原始细胞中高度上调,特异性阻断NG2导致几乎完全丧失植入。
  • 原代原始细胞和原代移植物的基因表达谱显示NG2+原始细胞具有迁移特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mixed-lineage leukemia (MLL)-rearranged (MLLr) infant B-cell acute lymphoblastic leukemia (iMLLr-B-ALL) has a dismal prognosis and is associated with a pro-B/mixed phenotype, therapy refractoriness and frequent central nervous system (CNS) disease/relapse. Neuron-glial antigen 2 (NG2) is specifically expressed in MLLr leukemias and is used in leukemia immunophenotyping because of its predictive value for MLLr acute leukemias. NG2 is involved in melanoma metastasis and brain development; however, its role in MLL-mediated leukemogenesis remains elusive. Here we evaluated whether NG2 distinguishes leukemia-initiating/propagating cells (L-ICs) and/or CNS-infiltrating cells (CNS-ICs) in iMLLr-B-ALL. Clinical data from the Interfant cohort of iMLLr-B-ALL demonstrated that high NG2 expression associates with lower event-free survival, higher number of circulating blasts and more frequent CNS disease/relapse. Serial xenotransplantation of primary MLL-AF4+ leukemias indicated that NG2 is a malleable marker that does not enrich for L-IC or CNS-IC in iMLLr-B-All. However, NG2 expression was highly upregulated in blasts infiltrating extramedullar hematopoietic sites and CNS, and specific blockage of NG2 resulted in almost complete loss of engraftment. Indeed, gene expression profiling of primary blasts and primografts revealed a migratory signature of NG2+ blasts. This study provides new insights on the biology of NG2 in iMLLr-B-ALL and suggests NG2 as a potential therapeutic target to reduce the risk of CNS disease/relapse and to provide safer CNS-directed therapies for iMLLr-B-ALL.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Prieto C, López-Millán B, Roca-Ho H, et al. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. Leukemia. 2017. PMID: 28943635. doi:10.1038/leu.2017.294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。